Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-348228
Filing Date
2012-08-10
Accepted
2012-08-09 19:41:02
Documents
10
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d351606d10q.htm 10-Q 626159
2 EX-31.1 d351606dex311.htm EX-31.1 6021
3 EX-31.2 d351606dex312.htm EX-31.2 6005
4 EX-32.1 d351606dex321.htm EX-32.1 4597
  Complete submission text file 0001193125-12-348228.txt   3745612

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT acrx-20120630.xml EX-101.INS 515929
6 XBRL TAXONOMY EXTENSION SCHEMA acrx-20120630.xsd EX-101.SCH 36964
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20120630_cal.xml EX-101.CAL 39631
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20120630_def.xml EX-101.DEF 138243
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20120630_lab.xml EX-101.LAB 275728
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20120630_pre.xml EX-101.PRE 199155
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 121022051
SIC: 2834 Pharmaceutical Preparations